Christopher Bowden

2016

In 2016, Christopher Bowden earned a total compensation of $1.8M as Chief Medical Officer at Agios Pharmaceuticals, a 23% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$174,440
Option Awards$1,145,987
Salary$436,091
Other$9,103
Total$1,765,621

Bowden received $1.1M in option awards, accounting for 65% of the total pay in 2016.

Bowden also received $174.4K in non-equity incentive plan, $436.1K in salary and $9.1K in other compensation.

Rankings

In 2016, Christopher Bowden's compensation ranked 5,467th out of 14,075 executives tracked by ExecPay. In other words, Bowden earned more than 61.2% of executives.

ClassificationRankingPercentile
All
5,467
out of 14,075
61st
Division
Manufacturing
1,959
out of 5,486
64th
Major group
Chemicals And Allied Products
620
out of 1,900
67th
Industry group
Drugs
463
out of 1,543
70th
Industry
Pharmaceutical Preparations
368
out of 1,173
69th
Source: SEC filing on April 18, 2018.

Bowden's colleagues

We found five more compensation records of executives who worked with Christopher Bowden at Agios Pharmaceuticals in 2016.

2016

Andrew Hirsch

Agios Pharmaceuticals

Chief Financial Officer

2016

Steve Hoerter

Agios Pharmaceuticals

Chief Commercial Officer

2016

David Schenkein

Agios Pharmaceuticals

Chief Executive Officer

2016

Scott Biller

Agios Pharmaceuticals

Chief Scientific Officer

2016

Glenn Goddard

Agios Pharmaceuticals

Former Sr. Vice President, Finance

News

In-depth

You may also like